The role of small intestinal bacterial overgrowth in cystic fibrosis: a randomized case-controlled clinical trial with rifaximin

The Microbiome in Cystic Fibrosis

(2016) Yvonne J. Huang et al.   CLINICS IN CHEST MEDICINE

Measurement of oro-caecal transit time by magnetic resonance imaging

(2015) Edoardo Savarino et al.   EUROPEAN RADIOLOGY

Small intestinal bacterial overgrowth: duodenal aspirationvsglucose breath test

(2015) A. Erdogan et al.   NEUROGASTROENTEROLOGY AND MOTILITY

Fecal Biomarkers of Intestinal Health and Disease in Children

(2014) Tamara Pang et al.   Frontiers in Pediatrics

Meta-analysis: antibiotic therapy for small intestinal bacterial overgrowth

(2013) S. C. Shah et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Review article: small intestinal bacterial overgrowth - prevalence, clinical features, current and developing diagnostic tests, and treatment

(2013) E. Grace et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Breath Testing for Small Intestinal Bacterial Overgrowth: Maximizing Test Accuracy

(2013) Richard J. Saad et al.   Clinical Gastroenterology and Hepatology

Delayed Small Bowel Transit in Children With Cystic Fibrosis and Pancreatic Insufficiency

(2013) Alisha J. Rovner et al.   JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION

Lactulose Breath Test to Assess Oro-cecal Transit Delay and Estimate Esophageal Dysmotility in Scleroderma Patients

(2013) Lorenzo Gemignani et al.   SEMINARS IN ARTHRITIS AND RHEUMATISM

Structure, function and diversity of the healthy human microbiome

(2012)   NATURE

Human gut microbiome viewed across age and geography

(2012) Tanya Yatsunenko et al.   NATURE

Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth

(2011) Aleksandra Lisowska et al.   Journal of Cystic Fibrosis

How to Interpret Hydrogen Breath Tests

(2011) Uday C Ghoshal   Journal of Neurogastroenterology and Motility

Clinical trial: the combination of rifaximin with partially hydrolysed guar gum is more effective than rifaximin alone in eradicating small intestinal bacterial overgrowth

(2010) M. Furnari et al.   ALIMENTARY PHARMACOLOGY & THERAPEUTICS

Combined oro-caecal scintigraphy and lactulose hydrogen breath testing demonstrate that breath testing detects oro-caecal transit, not small intestinal bacterial overgrowth in patients with IBS

(2010) D. Yu et al.   GUT

Long-term impacts of antibiotic exposure on the human intestinal microbiota

(2010) C. Jernberg et al.   MICROBIOLOGY-SGM

Small intestine bacterial overgrowth does not correspond to intestinal inflammation in cystic fibrosis

(2010) Aleksandra Lisowska et al.   SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION

Review of rifaximin as treatment for SIBO and IBS

(2009) Mark Pimentel   EXPERT OPINION ON INVESTIGATIONAL DRUGS

Lactulose Breath Testing Does Not Discriminate Patients With Irritable Bowel Syndrome From Healthy Controls

(2008) Jason R. Bratten et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Guidelines for Diagnosis of Cystic Fibrosis in Newborns through Older Adults: Cystic Fibrosis Foundation Consensus Report

(2008) Philip M. Farrell et al.   JOURNAL OF PEDIATRICS

The Pervasive Effects of an Antibiotic on the Human Gut Microbiota, as Revealed by Deep 16S rRNA Sequencing

(2008) Les Dethlefsen et al.   PLOS BIOLOGY